| 发明名称 |
FIXED DOSE COMBINATION FORMULATIONS OF RIFAXIMIN AND LACTULOSE |
| 摘要 |
A fixed dose combination formulation of rifaximin or a pharmaceutically acceptable salt thereof and lactulose is provided. The formulation is used for the prevention, treatment, or maintaining remission of HE; reducing the recurrence of HE episodes; reducing the recurrence of HE episodes in a patient refractory or non-responsive to rifaximin or lactulose monotherapy; or reducing the frequency of hospital visit. |
| 申请公布号 |
US2016243144(A1) |
申请公布日期 |
2016.08.25 |
| 申请号 |
US201615049293 |
申请日期 |
2016.02.22 |
| 申请人 |
Oakdene Holdings LLC |
发明人 |
Garegnani James;Trehan Aman |
| 分类号 |
A61K31/7016;A61K31/437;A61K9/00 |
主分类号 |
A61K31/7016 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An oral formulation comprising fixed dose combination of rifaximin or a pharmaceutically acceptable salt thereof and lactulose for preventing, treating, or maintaining remission of hepatic encephalopathy. |
| 地址 |
Mendham NJ US |
